Cel Sci

CVMNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$30.061 M

$1.72 +6.83%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$25.4M

Loss-making

Shares outstanding

8,493,111

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#137Estrella ImmunopharmaESLA$31.1M
#138Quince TherapeuticsQNCX$30.7M
#139Cel SciCVM$30.1M
#140Evaxion A/SEVAX$25.9M
#141Greenland MinesGRML$23.5M

Where these numbers come from

Share counts and financials for Cel Sci are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.